THE RELATIONSHIP BETWEEN SERUM ALKALINE-PHOSPHATASE AND VINCRISTINE NEUROPATHY - REPLY

被引：0
作者：
DESAI, ZR
VANDENBERG, HW
BRIDGES, JM
SHANKS, RG
机构：
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1983年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141 / 141
页数：1
相关论文
共 3 条
[1]   CAN SEVERE VINCRISTINE NEUROTOXICITY BE PREVENTED [J].
DESAI, ZR ;
VANDENBERG, HW ;
BRIDGES, JM ;
SHANKS, RG .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (02) :211-214
[2]   THE PHARMACOKINETICS OF VINCRISTINE IN MAN - REDUCED DRUG CLEARANCE ASSOCIATED WITH RAISED SERUM ALKALINE-PHOSPHATASE AND DOSE-LIMITED ELIMINATION [J].
VANDENBERG, HW ;
DESAI, ZR ;
WILSON, R ;
KENNEDY, G ;
BRIDGES, JM ;
SHANKS, RG .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (02) :215-219
[3]   HIGH INCIDENCE OF VINCRISTINE-INDUCED NEUROPATHY IN LYMPHOMAS [J].
WATKINS, SM ;
GRIFFIN, JP .
BRITISH MEDICAL JOURNAL, 1978, 1 (6113) :610-612
1